KP
Karyopharm Therapeutics Inc.
KPTI · NASDAQ
$1.79 +1.70% (+$0.03)
1M -8.21%
Market Cap $40.1M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.02
43.0% downside
Trenutna cena
$1.79
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KPTI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.27x
EV/EBITDA N/A
P/B N/A
Growth
8 /100
Declining Rev. growth 2.39%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 153.28%
Op. margin 56.17%
FCF margin 44.57%
Quality
79 /100
Excellent ROA 201.89%
Asset turnover 1.32x
ROIC 376.87%
Debt
11 /100
High Int. coverage -3.57x
Current ratio 0.79x
Net debt/EBITDA N/A
Stability
55 /100
Moderate Rev. volatility 4.10%
EPS volatility 77.87%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KPTI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard A. Paulson
Employees
228
Headquarters
Newton
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report